Published in Subst Abuse Treat Prev Policy on April 17, 2009
Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions? Mov Disord (2012) 1.03
Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol (2011) 0.83
Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment. J Subst Abuse Treat (2010) 0.81
Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study. Subst Abuse Treat Prev Policy (2012) 0.77
Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence. Forensic Sci Int (2010) 0.75
Working memory: looking back and looking forward. Nat Rev Neurosci (2003) 9.82
Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills (1977) 6.58
The neurobiology of consolidations, or, how stable is the engram? Annu Rev Psychol (2004) 6.33
Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci (1992) 4.57
An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat (2005) 3.46
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess (2007) 3.43
Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci U S A (1996) 2.27
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2003) 1.80
Cognitive impairment among methadone maintenance patients. Addiction (2000) 1.57
Cognitive performance of male adolescents is lower than controls across psychiatric disorders: a population-based study. Acta Psychiatr Scand (2004) 1.57
Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend (2002) 1.56
The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev (2008) 1.54
The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry (2005) 1.52
Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet (2005) 1.43
Neuroimaging the serial position curve. A test of single-store versus dual-store models. Psychol Sci (2005) 1.34
Dual processing in reasoning: two systems but one reasoner. Psychol Sci (2006) 1.33
Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev (2008) 1.31
Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol (2004) 1.31
Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol (1986) 1.30
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol (2007) 1.25
Assessment of memory complaint in age-associated memory impairment: the MAC-Q. Int Psychogeriatr (1992) 1.23
Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend (2004) 1.22
Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend (2005) 1.22
Neuropsychological deficits and opiate abuse. Drug Alcohol Depend (2002) 1.13
Ability to counselors to detect cognitive impairment among substance-abusing patients: an examination of diagnostic efficiency. Exp Clin Psychopharmacol (1997) 1.10
Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Clin Pharmacokinet (2004) 1.09
Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J Clin Psychopharmacol (2008) 1.04
Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. Eur J Pain (2004) 1.02
Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology (Berl) (2001) 1.02
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. J Clin Psychopharmacol (2006) 1.00
Behavioural pharmacology and its contribution to the molecular basis of memory consolidation. Behav Pharmacol (2000) 1.00
Alternate forms of the Auditory-Verbal Learning Test: issues of test comparability, longitudinal reliability, and moderating demographic variables. Arch Clin Neuropsychol (1995) 1.00
Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol (2006) 0.98
Self-report and objective measures of cognitive deficit in patients entering substance abuse treatment. Psychiatry Res (1999) 0.97
Additional methadone increases craving for heroin: a double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment. Addiction (1999) 0.97
Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials. J Clin Pharmacol (2006) 0.96
Eyes wide shut?--A conceptual and empirical critique of methadone maintenance treatment. Eur Addict Res (2005) 0.91
Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment. Am J Drug Alcohol Abuse (2008) 0.89
Neuropsychological deficits in female adolescents with a substance use disorder: better accounted for by conduct disorder? J Stud Alcohol (2000) 0.86
A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug Alcohol Depend (2004) 0.85
Lorazepam, sedation, and conscious recollection: a dose-response study with healthy volunteers. Int Clin Psychopharmacol (2002) 0.83
Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. Drug Alcohol Depend (2005) 0.82
Neuropsychological problems in everyday life: a 5-year follow-up study of young severely closed-head-injured patients. Brain Inj (1995) 0.82
Pharmacokinetics of buprenorphine: a comparison of sublingual tablet versus liquid after chronic dosing. J Addict Med (2007) 0.82
Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence. J Addict Dis (2006) 0.81
Acute effects of opioids on memory functions of healthy men and women. Psychopharmacology (Berl) (2008) 0.81
Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. J Clin Psychiatry (2007) 0.80
Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects. Neuropsychobiology (1999) 0.80
Effects of endogenous morphine deprivation on memory retention of passive avoidance learning in mice. Int J Neuropsychopharmacol (2004) 0.79
Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation, and plasma catecholamines. Neuropsychopharmacology (1993) 0.78
Character pathology and neuropsychological test performance in remitted opiate dependence. Subst Abuse Treat Prev Policy (2008) 0.78
Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory. Arch Gen Psychiatry (1977) 0.76
Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med (2013) 1.71
Right unilateral and bifrontal electroconvulsive therapy in the treatment of depression: a preliminary study. J ECT (2002) 1.47
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study. Cerebrovasc Dis (2009) 1.25
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol (2007) 1.25
Self-reported alcohol consumption and association to carbohydrate-deficient transferrin and gamma-glutamyltransferase in a random sample of the general population in the Republic of Karelia, Russia and in North Karelia, Finland. Alcohol Alcohol (2002) 1.18
AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey. Drug Alcohol Depend (2009) 1.15
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry (2008) 1.13
Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS Study. J Neurol Neurosurg Psychiatry (2006) 1.12
Hazardous drinking: prevalence and associations in the Finnish general population. Alcohol Clin Exp Res (2008) 1.08
Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage (2012) 1.07
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc Dis (2009) 1.04
A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol (2007) 0.98
Accuracy of quantity-frequency and graduated frequency questionnaires in measuring alcohol intake: comparison with daily diary and commonly used laboratory markers. Alcohol Alcohol (2002) 0.97
Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry (2006) 0.96
Depression-executive dysfunction syndrome in stroke patients. Am J Geriatr Psychiatry (2005) 0.93
Factors associated with disordered gambling in Finland. Subst Abuse Treat Prev Policy (2013) 0.92
The association of alcohol dependency with employment probability: evidence from the population survey 'Health 2000 in Finland'. Health Econ (2007) 0.91
Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy - Association of interleukin-8 and VEGF with survival. Cytokine (2009) 0.90
White matter lesions are related to impaired instrumental activities of daily living poststroke. J Stroke Cerebrovasc Dis (2007) 0.90
The Alcohol Use Disorders Identification Test (AUDIT) and its derivatives in screening for heavy drinking among the elderly. Int J Geriatr Psychiatry (2010) 0.89
A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone). Subst Abuse Treat Prev Policy (2008) 0.89
Abstaining from alcohol and labour market underperformance--have we forgotten the 'dry' alcoholics? Alcohol Alcohol (2006) 0.87
Alcohol consumption and all-cause mortality among elderly in Finland. Drug Alcohol Depend (2009) 0.86
Magnesium treatment in alcoholics: a randomized clinical trial. Subst Abuse Treat Prev Policy (2008) 0.85
An analysis of problem gambling among the Finnish working-age population: a population survey. BMC Public Health (2013) 0.85
Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication. Subst Abuse Treat Prev Policy (2008) 0.85
Short cognitive behavioral therapy and cognitive training for adults with ADHD - a randomized controlled pilot study. Neuropsychiatr Dis Treat (2010) 0.84
Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol (2011) 0.83
Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets. Eur Addict Res (2010) 0.83
Low verbal ability predicts later violence in adolescent boys with serious conduct problems. Nord J Psychiatry (2012) 0.82
Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapy. Free Radic Res (2009) 0.82
Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence. Psychiatry Res (2009) 0.82
Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients. Nord J Psychiatry (2010) 0.82
Exhaled pentane as a possible marker for survival and lipid peroxidation during radiotherapy for lung cancer--a pilot study. Free Radic Res (2009) 0.81
Attitudes towards gambling in Finland: a cross-sectional population study. BMC Public Health (2014) 0.81
μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption. Alcohol Alcohol (2013) 0.81
Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence. Psychiatry Res (2011) 0.80
Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study. Psychopharmacol Bull (2010) 0.80
Impact of radiotherapy and chemotherapy on biomarkers of oxidative DNA damage in lung cancer patients. Clin Biochem (2009) 0.79
Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone. J Stud Alcohol Drugs (2013) 0.79
Characteristics of Treatment Seeking Finnish Pathological Gamblers: Baseline Data from a Treatment Study. Int J Ment Health Addict (2013) 0.79
Clarifying the diversity of first-episode psychosis: Neuropsychological correlates of clinical symptoms. Nord J Psychiatry (2009) 0.78
Opposite associations of carbohydrate-deficient transferrin and gamma-glutamyltransferase with prevalent coronary heart disease. Arch Intern Med (2002) 0.78
Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone. Am J Drug Alcohol Abuse (2014) 0.78
Naltrexone for alcohol dependence. N Engl J Med (2002) 0.77
Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study. Subst Abuse Treat Prev Policy (2012) 0.77
A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling. Eur Addict Res (2015) 0.77
Concerned significant others of people with gambling problems in Finland: a cross-sectional population study. BMC Public Health (2014) 0.77
The impacts of nitrous oxide gas on sleep quality during alcohol withdrawal. BMC Res Notes (2011) 0.76
Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer. Clin Biochem (2009) 0.75
Right unilateral and bifrontal electroconvulsive therapy in the treatment of depression: a preliminary study. J ECT (2002) 0.75
Analysis of naltrexone and its metabolite 6-beta-naltrexol in serum with high-performance liquid chromatography. BMC Res Notes (2012) 0.75
[The Finnish first year junior high school students gambling behaviour is associated with substance use and low academic performance]. Duodecim (2015) 0.75
[Care of alcohol addiction]. Duodecim (2005) 0.75
[Designer drugs in Finland]. Duodecim (2011) 0.75
Lack of association between neuropsychological performance and level of psychosis-proneness in an adolescent psychiatric sample. J Nerv Ment Dis (2009) 0.75
Time-sharing strategies in driving after various cerebral lesions. Brain Inj (2004) 0.75
Do individuals with former amphetamine dependence have cognitive deficits? Nord J Psychiatry (2005) 0.75
[Investments of research and treatment of brain diseases will pay of time]. Duodecim (2014) 0.75
[Not Available]. Duodecim (2007) 0.75
[Not Available]. Duodecim (2006) 0.75
Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model. Eur J Gastroenterol Hepatol (2017) 0.75
Comparison of new alcohol use test, the Helsinki Alcohol Use Test questionnaire, and Alcohol Use Disorders Identification Test and laboratory markers serum gamma-glutamyl transferase and carbohydrate-deficient transferrin. Addict Behav (2004) 0.75
[Cognition disorders after cerebrovascular accidents]. Duodecim (2002) 0.75
The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus. Eur Addict Res (2015) 0.75
The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample. Schizophr Res (2010) 0.75
[Neurobiology of pathological gambling]. Duodecim (2009) 0.75